• SPX
  • $5,782.58
  • 0.55 %
  • $31.45
  • DJI
  • $42,414.87
  • 0.79 %
  • $334.50
  • N225
  • $39,277.96
  • 0.87 %
  • $340.42
  • FTSE
  • $8,243.92
  • 0.65 %
  • $53.31
  • IXIC
  • $18,248.94
  • 0.36 %
  • $66.02

This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

By Yahoo! Finance   |   Sep 18, 2024 at 10:26 AM EST
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments

Goldman Sachs predicts the anti-obesity market to reach $100 billion by 2030. Terns Pharmaceuticals may be a strong contender with its promising GLP-1 weight-loss pill. However, investors should be cautious due to the competitive market and uncertainties in the biotech industry.

Read More

Did you find this insightful?


We are preparing, please wait

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.